Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Journey Medical Corporation Reports Combined Emrosi Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
Homerun Resources Inc. Announces Closing of Initial Tranche of Convertible Security Financing with the Lind Partners Under Engagements with Benchmark/StoneX